Jiangsu Nhwa Pharmaceutical Co., Ltd. Jiangsu Nhwa Pharmaceutical Co., Ltd.

Jiangsu Nhwa Pharmaceutical Co., Ltd.

002262

Rankning i aktier #4693
Jiangsu Nhwa Pharmaceutical Co., LTD operates as a global pharmaceutical... Jiangsu Nhwa Pharmaceutical Co., LTD operates as a global pharmaceutical entity, focusing on the research, production, and sale of treatments for the central nervous system, along with cardiovascular and cerebrovascular ailments. Its comprehensive product line includes therapeutics for anesthesia, psychiatry, and neurological disorders. Additionally, the company is a supplier of Active Pharmaceutical Ingredients (APIs), specifically for central nervous system, anesthetic, and sedative applications, among others. The firm was established in 1978 and is based in Xuzhou, China.
Aktiekurs
$3.17
Marknadsvärde
$3.21B
Förändring (1 dag)
0.83%
Förändring (1 år)
-13.30%
Land
CN
Handel Jiangsu Nhwa Pharmaceutical Co., Ltd. (002262)

Kategori

Healthcare
Utdelningsavkastning för Jiangsu Nhwa Pharmaceutical Co., Ltd. (002262)
Utdelningsavkastningen (TTM) för Jiangsu Nhwa Pharmaceutical Co., Ltd. (aktiesymbol: 002262) per 2023-12-31 är: 0.73%
Genomsnittlig utdelningsavkastning de senaste 5 åren: 0.82%
Historik för utdelningsavkastning för Jiangsu Nhwa Pharmaceutical Co., Ltd. (002262) från 2005 till 2026
Utdelningsavkastning i slutet av varje år (TTM)
År Utdelningsavkastning Ändra
2026 (TTM) 1.89% 44.27%
2024 1.31% 79.45%
2023 0.73% -9.88%
2022 0.81% 26.56%
2021 0.64% 1.59%
2020 0.63% -4.55%
2019 0.66% -9.59%
2018 0.73% 121.21%
2017 0.33% 6.45%
2016 0.31% 6.90%
2015 0.29% -23.68%
2014 0.38% -2.56%
2013 0.39% -22.00%
2012 0.50% -29.58%
2011 0.71% 69.05%
2010 0.42% -53.85%
2009 0.91% -22.88%
2008 1.18% 93.44%
2007 0.61% -72.40%
2006 2.21% 190.79%
2005 0.76% 0.00%
Utdelningsavkastning (TTM) för liknande företag eller konkurrenter